We are excited to meet you at ARVO! Starting Sunday, May 4, you’ll find us at booth #1825, ready for great conversations. Come discover how our cutting-edge research services can accelerate your drug development pipeline – our team will be there to discuss your needs, share insights, and explore potential collaborations. You can schedule a meeting with our CBO Guillaume Demarne, in advance by simply clicking this link.

Scientific posters

We also invite you to explore the scientific posters. We have prepared seven interesting posters, please see the information below. You can already find the abstracts in the ARVO 2025 mobile app – don’t forget to schedule them into your busy meeting days!

Sunday, May 4, 2025, 1:00 – 2:45 PM
Robertas Čėsna
Thioredoxin system and HIF1a pathway activation by oxidative stress in human iPSC-RPE cells
#746 – B0083

Monday, May 5, 2025, 3:00 – 4:45 PM
Dovilė Litvinavičiūtė
Human cornea-on-a-chip – opportunities and challenges
#2301 – A0538

Maria Vähätupa
Phosphate-buffered saline administered intravitreally at P12 blocks neovascularization in the mouse oxygen-induced retinopathy model
#2570 – B0283

Xavier Ekolle
Triamcinolone delays retinal atrophy in a mouse laser-induced geographic atrophy model
# 2521 – B0234

Leena Tähtivaara
Comparison of blue light-induced damage (BLD) in albino and pigmented mice
# 2528 – B0241

Tuesday, May 6, 2025, 1:15 – 3:00 PM
Inesa Lelyte
Combined administration of BDNF and CNTF provides superior neuroprotection as compared to BDNF alone in a mouse optic nerve crush model
#3436 – A0456

Wednesday, May 7, 2025, 2:00 – 3:45 PM
Kernius Mickevicius
Morphological, functional, and behavioral alterations in a microbead-induced mouse glaucoma model
#4964 – A0538

Experience our facility in 360o

This year, you can also take a virtual trip to our laboratories in Lithuania using VR glasses – come and experience our site in a whole new way!

We look forward to seeing you soon!

Guillaume Demarne

Guillaume Demarne

, PharmD

Chief Business Officer